These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13158766)

  • 1. The therapeutic effect on a group of sleeping sickness patients of a single injection of 3854 R.P. (mel B Friedheim-arsobal Spécia).
    PINTO AR
    Am J Trop Med Hyg; 1954 May; 3(3):464-5. PubMed ID: 13158766
    [No Abstract]   [Full Text] [Related]  

  • 2. Arsobal in the treatment of Rhodesian sleeping-sickness.
    SILVA MA; CASEIRO A; CARMO RP; DE BASTO AX
    An Inst Med Trop (Lisb); 1954 Jun; 11(2):261-85. PubMed ID: 13314057
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of advanced cases of Rhodesian sleeping sickness by Mel. B. and arsobal.
    APTED FI
    Trans R Soc Trop Med Hyg; 1953 Sep; 47(5):387-98. PubMed ID: 13102579
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of arsobal in the treatment of sleeping sickness].
    NEUJEAN G
    An Inst Med Trop (Lisb); 1952 Sep; 9(3):757-61. PubMed ID: 13092457
    [No Abstract]   [Full Text] [Related]  

  • 5. [New contribution on arsobal (R.P. 3854) therapy of trypanosomiasis; its effectiveness in former trypanosomiasis patients, with meningoencephalitis, resistant to trypanocides customarily used].
    CECCALDI J
    Bull Soc Pathol Exot Filiales; 1953; 46(1):95-121. PubMed ID: 13066959
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the urinary elimination of R.P. 3854 (mel-B Friedheim, arsobal Specia)].
    MONNET A; BAYLET R
    Med Trop (Mars); 1951; 11(6):893-902. PubMed ID: 14918686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the therapeutic value of arsobal in trypanosomiasis caused by Trypanosoma gambiense].
    BURKE J
    Ann Soc Belg Med Trop (1920); 1957 Apr; 37(2):175-90. PubMed ID: 13459025
    [No Abstract]   [Full Text] [Related]  

  • 8. Mel W, a new trypanosomicidal agent derived from mel B.
    FRIEDHEIM EA; DE JONGH RT
    Trans R Soc Trop Med Hyg; 1959 May; 53(3):262-9. PubMed ID: 13669031
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
    Pialoux G; Kernbaum S; Vachon F
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of advanced trypanosomiasis rhodesiense with mel B.
    TAUBE E; NIXON LC
    Cent Afr J Med; 1958 Apr; 4(4):141-7. PubMed ID: 13547140
    [No Abstract]   [Full Text] [Related]  

  • 11. Mel B in the treatment of tryparsamide resistant T. gambiense sleeping sickness: observations on drug resistance in the trypanosomes of the French Cameroun.
    FRIEDHEIM EA
    Am J Trop Med Hyg; 1951 Mar; 31(2):218-35. PubMed ID: 14819516
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of trepolysin (4000 M) or m-amino-p-hydroxyphenylarsenoxy camphorsulfonate in the treatment of sleeping sickness].
    CECCALDI J; TRINQUIER E; ARNOULT H
    Bull Soc Pathol Exot Filiales; 1953; 46(1):87-95. PubMed ID: 13066958
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 May; 57():176-83. PubMed ID: 13974351
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 Mar; 57():122-33. PubMed ID: 13974350
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
    Bales JD; Harrison SM; Mbwabi DL; Schecter PJ
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():111-4. PubMed ID: 2515816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EEG and treatment with Arsobal in human African trypanosomiasis].
    Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Mel B arsobal and alpha-difluoromethylornithine on the awakening electroencephalogram of humans with gambiense trypanosomiasis disease: preliminary report.
    Hamon JF; Seri B; Doua F; Camara P; Aba L
    Pharmacol Biochem Behav; 1990 Aug; 36(4):831-5. PubMed ID: 2217510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
    Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)].
    Sina GC; Triolo N; Cramet B; Suh Bandu M
    Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.